Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma

Published:2016-04-04 Issue:10 Volume:36 Page:1498-1506
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Hsu Chia-Yang¹²³,Liu Po-Hong¹²,Hsia Cheng-Yuan²⁴,Lee Yun-Hsuan¹²,Al Juboori Alhareth³,Lee Rheun-Chuan²⁵,Lin Han-Chieh¹²,Huo Teh-Ia¹²⁶

Affiliation:

1. Department of Medicine; Taipei Veterans General Hospital; Taipei Taiwan

2. Faculty of Medicine; National Yang-Ming University School of Medicine; Taipei Taiwan

3. Department of Internal Medicine; University of Nevada School of Medicine; Reno NV USA

4. Department of Surgery; Taipei Veterans General Hospital; Taipei Taiwan

5. Department of Radiology; Taipei Veterans General Hospital; Taipei Taiwan

6. Institute of Pharmacology; National Yang-Ming University School of Medicine; Taipei Taiwan

Funder

Center of Excellence for Cancer Research

Taipei Veterans General Hospital

Ministry of Education

Aiming for the Top University Plan

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13114/fullpdf

Reference31 articles.

1. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry;Weinmann;J Clin Gastroenterol,2014

2. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma;Yau;Gastroenterology,2014

3. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort;Marrero;Hepatology,2005

4. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System;Hsu;J Hepatol,2010

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver;J Hepatol,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and validation of a prognostic nomogram for patients with distant metastatic gallbladder cancer based on treatment benefits;2023-09-08

2. Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma;Hepatology International;2023-01-04

3. Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization;Journal of Hepatocellular Carcinoma;2022-06

4. Development and Validation of a Gene Mutation-Associated Nomogram for Hepatocellular Carcinoma Patients From Four Countries;Frontiers in Genetics;2021-09-21

5. Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China;Translational Cancer Research;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3